LEXX Cash from Financing Activities - Cash Flow Statement - Lexaria Bioscience Corp. - IntrinsicAlpha

Lexaria Bioscience Corp. LEXX

Healthcare - Biotechnology - NASDAQ - CA

$ 1.9

-3.8 %

$ 33.3 M

Market Cap

-3.8

P/E

LEXX - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities LEXX - Lexaria Bioscience Corp.

10.3 M

LAST VALUE

1427.36%

2 YEAR CAGR

25.35%

5 YEAR CAGR

40.62%

10 YEAR CAGR